目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Antithrombotic drugs - Market size and forecast 2020-2025
Hypolipidemic drugs - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
Asia - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Astellas Pharma Inc.
Eli Lilly and Co.
GlaxoSmithKline Plc
Johnson and Johnson Inc.
Merck and Co. Inc.
Pfizer Inc.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ billion)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Antithrombotic drugs - Market size and forecast 2020-2025 ($ billion)
24: Antithrombotic drugs - Year-over-year growth 2020-2025 (%)
25: Hypolipidemic drugs - Market size and forecast 2020-2025 ($ billion)
26: Hypolipidemic drugs - Year-over-year growth 2020-2025 (%)
27: Others - Market size and forecast 2020-2025 ($ billion)
28: Others - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Product
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: Asia - Market size and forecast 2020-2025 ($ billion)
34: Asia - Year-over-year growth 2020-2025 (%)
35: North America - Market size and forecast 2020-2025 ($ billion)
36: North America - Year-over-year growth 2020-2025 (%)
37: Europe - Market size and forecast 2020-2025 ($ billion)
38: Europe - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ billion)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ billion)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Astellas Pharma Inc. - Overview
50: Astellas Pharma Inc. - Product and service
51: Astellas Pharma Inc. - Key offerings
52: Astellas Pharma Inc. - Key customers
53: Astellas Pharma Inc. - Segment focus
54: Eli Lilly and Co. - Overview
55: Eli Lilly and Co. - Business segments
56: Eli Lilly and Co. - Key offerings
57: Eli Lilly and Co. - Key customers
58: Eli Lilly and Co. - Segment focus
59: GlaxoSmithKline Plc - Overview
60: GlaxoSmithKline Plc - Business segments
61: GlaxoSmithKline Plc - Key offerings
62: GlaxoSmithKline Plc - Key customers
63: GlaxoSmithKline Plc - Segment focus
64: Johnson and Johnson Inc. - Overview
65: Johnson and Johnson Inc. - Business segments
66: Johnson and Johnson Inc. - Key offerings
67: Johnson and Johnson Inc. - Key customers
68: Johnson and Johnson Inc. - Segment focus
69: Merck and Co. Inc. - Overview
70: Merck and Co. Inc. - Business segments
71: Merck and Co. Inc. - Key offerings
72: Merck and Co. Inc. - Key customers
73: Merck and Co. Inc. - Segment focus
74: Pfizer Inc. - Overview
75: Pfizer Inc. - Business segments
76: Pfizer Inc. - Key offerings
77: Pfizer Inc. - Key customers
78: Pfizer Inc. - Segment focus
79: Sanofi SA - Overview
80: Sanofi SA - Business segments
81: Sanofi SA - Key offerings
82: Sanofi SA - Key customers
83: Sanofi SA - Segment focus
84: Sun Pharmaceutical Industries Ltd. - Overview
85: Sun Pharmaceutical Industries Ltd. - Business segments
86: Sun Pharmaceutical Industries Ltd. - Key offerings
87: Sun Pharmaceutical Industries Ltd. - Key customers
88: Sun Pharmaceutical Industries Ltd. - Segment focus
89: Teva Pharmaceutical Industries Ltd. - Overview
90: Teva Pharmaceutical Industries Ltd. - Business segments
91: Teva Pharmaceutical Industries Ltd. - Key offerings
92: Teva Pharmaceutical Industries Ltd. - Key customers
93: Teva Pharmaceutical Industries Ltd. - Segment focus
94: Viatris Inc. - Overview
95: Viatris Inc. - Business segments
96: Viatris Inc. - Key offerings
97: Viatris Inc. - Key customers
98: Viatris Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations